E. Swisher

782 total citations
9 papers, 384 citations indexed

About

E. Swisher is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, E. Swisher has authored 9 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Molecular Biology. Recurrent topics in E. Swisher's work include PARP inhibition in cancer therapy (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cardiac electrophysiology and arrhythmias (1 paper). E. Swisher is often cited by papers focused on PARP inhibition in cancer therapy (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cardiac electrophysiology and arrhythmias (1 paper). E. Swisher collaborates with scholars based in United States, United Kingdom and Canada. E. Swisher's co-authors include Kristen M. Shannon, R. Burt, Lana N. Pho, Robert Pilarski, Robert L. Coleman, Gottfried E. Konecny, Lara Maloney, David M. O’Malley, Iain A. McNeish and Andrea Wahner Hendrickson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E. Swisher

9 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Swisher United States	4	177	123	98	92	57	9	384
Capucine Delnatte France	9	219 1.2×	100 0.8×	136 1.4×	144 1.6×	56 1.0×	15	426
Mamoru Ozaki Japan	12	152 0.9×	64 0.5×	56 0.6×	142 1.5×	59 1.0×	38	389
Anna Laura Putignano Italy	11	130 0.7×	96 0.8×	54 0.6×	127 1.4×	36 0.6×	17	316
Emmanuelle Barouk-Simonet France	4	160 0.9×	72 0.6×	70 0.7×	93 1.0×	18 0.3×	11	287
Alexandra Friemel Germany	15	223 1.3×	113 0.9×	18 0.2×	63 0.7×	67 1.2×	24	519
Xin-Yan Lu United States	6	321 1.8×	178 1.4×	69 0.7×	157 1.7×	45 0.8×	7	594
Jeffrey M. Cloutier United States	14	538 3.0×	106 0.9×	70 0.7×	150 1.6×	25 0.4×	46	798
Stavros Giannakopoulos United States	6	382 2.2×	61 0.5×	123 1.3×	54 0.6×	14 0.2×	8	460
Lukasz M. Szafron Poland	11	318 1.8×	83 0.7×	102 1.0×	44 0.5×	17 0.3×	27	427
Christin Sciulli United States	9	206 1.2×	157 1.3×	116 1.2×	44 0.5×	54 0.9×	10	447

Countries citing papers authored by E. Swisher

Since Specialization

Citations

This map shows the geographic impact of E. Swisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Swisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Swisher more than expected).

Fields of papers citing papers by E. Swisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Swisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Swisher. The network helps show where E. Swisher may publish in the future.

Co-authorship network of co-authors of E. Swisher

This figure shows the co-authorship network connecting the top 25 collaborators of E. Swisher. A scholar is included among the top collaborators of E. Swisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Swisher. E. Swisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ghisoni, Eleonora, Fabrizio Benedetti, Paula Cunnea, et al.. (2022). 27MO Integrated digital pathology and single-cell analysis identify the spatial and temporal evolution of immune cells networks in epithelial ovarian cancer. Annals of Oncology. 33. S395–S395. 1 indexed citations

Swisher, E., Scott H. Kaufmann, M. J. Birrer, et al.. (2020). Exploring the relationship between homologous recombination score and progression-free survival in BRCA wildtype ovarian carcinoma: Analysis of veliparib plus carboplatin/paclitaxel in the velia study. Gynecologic Oncology. 159. 51–51. 4 indexed citations

Hendrickson, Andrea E. Wahner, B. Costello, Andrea Jewell, et al.. (2018). A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer. Annals of Oncology. 29. viii357–viii357. 1 indexed citations

Oaknin, Ana, Anna V. Tinker, I. Ray-Coquard, et al.. (2017). Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC). European Journal of Cancer. 72. S95–S95. 2 indexed citations

Lin, Ken Y., Anna V. Tinker, Olga Kondrashova, et al.. (2016). Secondary mutations in RAD51C and RAD51D are associated with acquired resistance to the PARP inhibitor rucaparib in patients with high-grade ovarian cancer. European Journal of Cancer. 69. S13–S13. 3 indexed citations

Piskorz, Anna, Kevin Lin, Jeffrey S. Morris, et al.. (2016). Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial. European Journal of Cancer. 69. S123–S123. 1 indexed citations

Swisher, E., Amit M. Oza, Robert L. Coleman, et al.. (2015). Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: Interim results for ARIEL2 clinical trial. Gynecologic Oncology. 138. 4–4. 6 indexed citations

Swisher, E., James D. Brenton, Amit M. Oza, et al.. (2014). 215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib. European Journal of Cancer. 50. 73–73. 9 indexed citations

Pilarski, Robert, et al.. (2013). Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. JNCI Journal of the National Cancer Institute. 105(21). 1607–1616. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact